Evidence map›Paper›PMID 21804195›Full record

ReviewThe Journal of clinical investigation2011

Recent advances in the molecular pathophysiology of atrial fibrillation.

Reza Wakili, Niels Voigt, Stefan Kääb, Dobromir Dobrev, Stanley Nattel

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in The Journal of clinical investigation, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01863979 (New Causes and Predictors for the Development of Atrial Fibrillation and Its Complications), which is not on this map. Cited by 274 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
274citing papers in PubMed, 4 pooled it
34.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01863979 completednot on this map

New Causes and Predictors for the Development of Atrial Fibrillation and Its Complications

TypeobservationalSponsorRambam Health Care CampusRan2007 to 2012Enrolled500ConditionsComplications of Atrial Fibrillation
3 · Its place in the literature

Who cites it

274 citing papers in PubMed, 4 syntheses or guidelines pooled it, 539 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2018
    Guideline
  4. Guideline
  5. Trial
  6. A Mechanistic Clinical Trial Using (Circulation. Arrhythmia and electrophysiology · 2022
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Understanding the Diseased Atria.Physiology (Bethesda, Md.) · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Differential effects of semaglutide and colchicine on atrial remodeling in rats with reduced ejection fraction after myocardial infarction.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  18. Article
  19. Review
  20. Observational

214 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Reza WakiliResearch Center, Department of Medicine, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.
Niels Voigt
Stefan Kääb
Dobromir Dobrev
Stanley Nattel
Heidelberg University · DELudwig-Maximilians-Universität München · DEUniversity Medical Centre Mannheim · DE

Funding

Canadian Institutes of Health Research MGP6957Canadian Institutes of Health Research MOP44365
6 · The paper itself

Abstract

Atrial fibrillation (AF) is an extremely common cardiac rhythm disorder that causes substantial morbidity and contributes to mortality. The mechanisms underlying AF are complex, involving both increased spontaneous ectopic firing of atrial cells and impulse reentry through atrial tissue. Over the past ten years, there has been enormous progress in understanding the underlying molecular pathobiology. This article reviews the basic mechanisms and molecular processes causing AF. We discuss the ways in which cardiac disease states, extracardiac factors, and abnormal genetic control lead to the arrhythmia. We conclude with a discussion of the potential therapeutic implications that might arise from an improved mechanistic understanding.

Indexed as

Atrial FibrillationCardiologyCell ProliferationElectrocardiographyGenetic Predisposition to DiseaseGenetic VariationHeart AtriaHeart VentriclesHumansModels, BiologicalModels, GeneticMyocardial ContractionPhosphorylationSignal Transduction

Identifiers

PMID21804195
PMCPMC3148739
OpenAlexW2057046598

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.